Person profile

Public information reviewed

Srinivas Akkaraju, M.D., Ph.D.

Board role

Director · Kalaris Therapeutics, Inc. (NASDAQ: KLRS)

Board role

Director · ALUMIS INC. (NASDAQ: ALMS)

Board role

Director · vTv Therapeutics Inc. (NASDAQ: VTVT)

Board role

Director · Scholar Rock Holding Corp (NASDAQ: SRRK)

Kalaris Therapeutics, Inc. (NASDAQ: KLRS)

Director · Current mandate

Director · Executive · Board
FollowSave PDF
More
Reports & analysisAlpha Eval
Public sources
9 reviewed
Profile ownership
Not yet claimed
Last reviewed
May 15, 2026
View sources

Profile

Identity, professional record and current appointments.

Overview

Professional record at a glance

A concise summary of information supported by the cited public sources. Missing information is treated as unknown, not as a negative finding.

Current roles
44 current organizations shown on this profile
Board positions
44 supported by public sources, 0 supplied by the profile owner
Committee roles
3Roles supported by the sources cited on this profile
Qualifications
Not establishedNo qualification is currently confirmed by the cited sources

Professional narrative

About

Alpha has not published a narrative summary because the current public source set is not sufficient.

Current roles

Appointments & responsibilities

Board appointments

Governance

Board appointments, committee responsibilities and disclosed relationships.

Connections

Explore the roles, education and affiliations published in this record.

ALUMIS INC.

Open ALUMIS INC. profile →

Director at ALUMIS INC.

2024-01-01 → End not stated

current · source reported

Observed: 2026-09-13

ALUMIS INC.ALUMIS INC.Kalaris Therapeuti…Kalaris Therapeutics, Inc.Scholar Rock Holdi…Scholar Rock Holding CorpvTv Therapeutics I…vTv Therapeutics Inc.Srinivas Akkaraju,…

Dashed lines mark past roles. Select a connection to see its dates and sources.

Relationship map

Connected through the public record

Direct relationships from verified facts and published résumé records. Private connections are excluded.

Direct public links only

Only published affiliations are shown here. Private relationships require authorized access.

Experience

Career history, education, credentials and public contributions.

Published record

Featured coverage

Selected publications and public sources used to establish this profile. Inclusion records provenance; it is not an endorsement.

Source 1 · Sec FilingKalaris Therapeutics, Inc. director board sourceSupports Board membership, Committee assignments, Director since, Board independence.Open sourceSource 2 · Sec FilingScholar Rock Holding director board sourceSupports Board membership, Committee assignments, Director since, Board independence.Open sourceSource 3 · Sec FilingALMS DEF 14A director slateSupports AI and ML experience, Board role, Committee assignments, Cybersecurity experience, Technology background.Open sourceSource 4 · Sec ProxyPublic profile sourceSupports Director at vTv Therapeutics Inc. (NASDAQ: VTVT), Board membership.Open source

Basis

Identifiers, sources, dates and record limitations.

Identifiers

Alpha ID
alpha:person:srinivas-akkaraju-m-d-ph-d
Record version
public-0

Sources

Sources and published information

Each item links to the public source used to support it. When sources disagree, the item is clearly marked for review.

AI and ML experience · Source reportedAI and ML experience: not identified in the cited filing1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Board independence · Under reviewNot independent (executive director)1 source
Verification
Under review
Confidence
95%
Last reviewed
May 3, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Board independence · Under reviewIndependent director1 source
Verification
Under review
Confidence
95%
Last reviewed
May 3, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Board membership · CorroboratedServes on the board of Kalaris Therapeutics, Inc.Supported by 3 public records2 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Board membership · CorroboratedServes on the board of Scholar Rock HoldingSupported by 4 public records3 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 15, 2026
Board membership · CorroboratedServes on the board of vTv Therapeutics Inc.Supported by 3 public records3 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 15, 2026
Board role · CorroboratedBoard role: DirectorSupported by 3 public records3 sources
Verification
Corroborated
Confidence
92%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 1, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed Apr 29, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Committee assignments · CorroboratedNo committee assignment disclosed in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Committee assignments · Source reportedCommittee assignments: Audit1 source
Verification
Source reported
Confidence
88%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Committee assignments · Source reportedCommittee assignments: Nominating/Governance1 source
Verification
Source reported
Confidence
88%
Last reviewed
May 1, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 1, 2026

Committee assignments · Source reportedCommittee assignments: Nominating/Governance, Science/Innovation1 source
Verification
Source reported
Confidence
88%
Last reviewed
Apr 29, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed Apr 29, 2026

Cybersecurity experience · Source reportedCybersecurity experience: not identified in the cited filing1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Executive company · Source reportedExecutive at Samsara BioCapital L.P.1 source
Verification
Source reported
Confidence
85%
Last reviewed
May 1, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 1, 2026

Executive title · Source reportedExecutive title: Founder and Managing General Partner1 source
Verification
Source reported
Confidence
85%
Last reviewed
May 1, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 1, 2026

Technology background · Source reportedTechnology background: not identified in the cited filing1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

View all sources9 records
  1. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

    Supports: Board membership · Committee assignments · Director since · Board independence

  2. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 1, 2026

    Supports: Board role · Committee assignments · Executive company · Executive title

  3. https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm

    Sec Proxy · Tier not stated · Reviewed Apr 24, 2026

    Supports: Director at Kalaris Therapeutics, Inc. (NASDAQ: KLRS)

  4. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

    Supports: Board membership · Committee assignments · Director since · Board independence

  5. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed Apr 29, 2026

    Supports: Board role · Committee assignments

  6. https://www.sec.gov/Archives/edgar/data/1727196/000110465926046917/tm261440-1_def14a.htm

    Sec Proxy · Tier not stated · Reviewed Apr 29, 2026

    Supports: Director at Scholar Rock Holding Corp (NASDAQ: SRRK) · Board membership

  7. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

    Supports: AI and ML experience · Board role · Committee assignments · Cybersecurity experience · Technology background

  8. https://www.sec.gov/Archives/edgar/data/1847367/000110465925059837/tm2515405-1_def14a.htm

    Sec Proxy · Tier not stated · Reviewed Apr 24, 2026

    Supports: Director at ALUMIS INC. (NASDAQ: ALMS)

  9. https://www.sec.gov/Archives/edgar/data/1641489/000164148925000024/vtvt-20250425.htm

    Sec Proxy · Tier not stated · Reviewed Apr 28, 2026

    Supports: Director at vTv Therapeutics Inc. (NASDAQ: VTVT) · Board membership